Products for Research Use Only
RegisterLogin

Bevacizumab

CAT: 0013-GTR19157775-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19157775-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
CAS Number
216974-75-3
Purity
>98% (HPLC)
Molecular Formula
——
Molecular Weight
149 kDa
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.

Alternative Products

CatalogName
HY-P9906-01Bevacizumab
CK-bio-28214-01Bevacizumab (Bevacizumab) ELISA Kit
JL58181-01Human Bevacizumab (Bevacizumab) ELISA Kit
abx376595-01Bevacizumab Antibody
CBA1029-01Bevacizumab Biosimilar
AR-B01549-01Bevacizumab (Avastin)
HB941026-01Research Grade Bevacizumab
DB941018Bevacizumab ELISA Kit
ABS-524-50ugBevacizumab Polyclonal Antibody
A2006-1mg*25Bevacizumab (anti-VEGF)

Popular Products